| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2343061A1 Use of tall oil pitch extract and compositions which contain it |
| 07/13/2011 | EP2343047A2 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 07/13/2011 | EP2342975A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342568A1 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 07/13/2011 | EP2342233A1 Anti cxcr4 antibodies and their use for the treatment of cancer |
| 07/13/2011 | EP2342230A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 07/13/2011 | EP2342227A1 Treatment of acute lymphoblastic leukemia |
| 07/13/2011 | EP2342226A2 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
| 07/13/2011 | EP2342202A1 Azaindole derivative |
| 07/13/2011 | EP2342200A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342199A2 Compounds which selectively modulate the cb2 receptor |
| 07/13/2011 | EP2342195A2 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt |
| 07/13/2011 | EP2342185A1 Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341928A1 Mycobacterium tuberculosis vaccine |
| 07/13/2011 | EP2341927A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 07/13/2011 | EP2341913A1 Method of enhancing tgf-beta signalling |
| 07/13/2011 | EP2341911A2 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 07/13/2011 | EP2341906A2 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors |
| 07/13/2011 | EP2341897A2 Nanoparticles for immunotherapy |
| 07/13/2011 | EP2341775A1 Inhibitors of janus kinases |
| 07/13/2011 | EP2341774A1 Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP2137147B1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP1975158B1 Novel pyrrole derivatives with histone deacetylase inhibitor activity |
| 07/13/2011 | EP1937310B8 Use of conjugates of doxorubicin with lactosaminated albumin |
| 07/13/2011 | EP1912066B1 Auxiliary method for diagnosis and therapy of cancer with nucleolin |
| 07/13/2011 | EP1812466B1 Compositions and methods for the control of mammary cell number |
| 07/13/2011 | EP1718322B1 Synergistic compositions with fk-228 |
| 07/13/2011 | EP1667655B1 New use, pharmaceutical preparations as well as a process for their production |
| 07/13/2011 | EP1633784B1 Ovr110 antibody compositions and methods of use |
| 07/13/2011 | EP1545553B1 Use of alkyl phosphocholines in combination with antitumor medicaments |
| 07/13/2011 | EP1524986B1 Metal cluster nano-compounds for treating tumor diseases |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1265878B1 A process for the preparation of epothilone analogs and intermediates |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | CN1902193B Quinoxalines useful as inhibitors of protein kinases |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN102124104A Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase |
| 07/13/2011 | CN102124009A Kinase inhibitors and methods of use |
| 07/13/2011 | CN102124007A Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102124006A Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 07/13/2011 | CN102124005A Cmet inhibitors |
| 07/13/2011 | CN102124004A Azaindole inhibitors of iap |
| 07/13/2011 | CN102124001A Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102124000A Pyridine compounds |
| 07/13/2011 | CN102123991A 2 -arylaminoquinazolines for treating proliferative diseases |
| 07/13/2011 | CN102123989A Pyrazole compounds 436 |
| 07/13/2011 | CN102123988A Squaric acid derivatives as inhibitors of the nicotinamide |
| 07/13/2011 | CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123733A Composition comprising a complexed (m)RNA and a naked (m)RNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 07/13/2011 | CN102123732A Compositions, methods and kits for eliciting an immune response |
| 07/13/2011 | CN102123731A Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 07/13/2011 | CN102123719A Plant extract and its therapeutic use |
| 07/13/2011 | CN102123712A Methods of cancer treatment with IGF1R inhibitors |
| 07/13/2011 | CN102123710A Bicyclic triazole derivatives for treating tumors |
| 07/13/2011 | CN102123709A A3 adenosine receptor allosteric modulators |
| 07/13/2011 | CN102123708A 8-hydroxyquinoline derivatives for the treatment of hematological malignancies |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120751A Nucleoside compound with anti-cancer and anti-virus activities, and preparation method and application thereof |
| 07/13/2011 | CN102120743A Novel anti-tumor epoxy-containing eremophilane sesquiterpene lactone |
| 07/13/2011 | CN102120736A Novel antineoplastic chlorine-containing eremophilane sesquiterpenes |
| 07/13/2011 | CN102120730A 19-S-methyl geldanamycin and 4,5-dihydrogen-19-S-methyl geldanamycin and preparation method thereof |
| 07/13/2011 | CN102120036A Nano micelle of biodegradable macromolecular-bonding Pt(IV) anti-cancer medicament and preparation method thereof |
| 07/13/2011 | CN102120032A Water-soluble substrate suitable for preparing water-soluble preparations of bleomycin and homologues thereof |
| 07/13/2011 | CN102120029A Preparation method of alginate microparticles capable of inducing tumor immune response |
| 07/13/2011 | CN102120024A Chinese medicinal oral decoction for treating hysteromyoma |
| 07/13/2011 | CN102120014A Chinese medicinal oral decoction for treating hysteromyoma |
| 07/13/2011 | CN102119958A Medicinal composition containing realgar |
| 07/13/2011 | CN102119953A Application of euphorbia humifusa wild extract |
| 07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
| 07/13/2011 | CN102119937A Application of scorpion venom injection in treatment of cancers |
| 07/13/2011 | CN102119917A Preparation method of recombinant human endostatin temperature sensitive gel |
| 07/13/2011 | CN101518644B Application of Ang-2 and genes thereof in pharmacy |
| 07/13/2011 | CN101402555B Method of preparing (Z)-3'-hydroxyl-3,4,4',5-tetramethoxy toluylene |
| 07/13/2011 | CN101376892B Herpes simplex virus vector, recombinant virus, host cell and pharmaceutical composition thereof |
| 07/13/2011 | CN101351444B Novel pyrrole derivates with histone deacetylation enzyme inhibition activity |
| 07/13/2011 | CN101347626B Vascularized specific polypeptide for marking tumor by radioactive nucleus and uses thereof |
| 07/13/2011 | CN101282926B S1p3 receptor antagonist |
| 07/13/2011 | CN101264278B Chinese medicinal composition for treating leukemia and producing method thereof |
| 07/13/2011 | CN101264268B Proprietary Chinese medicine for treating tumor |
| 07/13/2011 | CN101190917B 3,4-dihydro-3-methyl-4-oxomidazo[5,1-d]-1,2,3,5-tetrazine-8-formic acid benzenesulfonyl furoxan esters compound, preparation method and use thereof |
| 07/13/2011 | CN101190213B Docetaxel injection and preparation method thereof |
| 07/13/2011 | CN101123954B Anti-tumor agent |
| 07/13/2011 | CN101113169B Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 07/13/2011 | CN101094853B Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 07/13/2011 | CN101065482B Novel shuttle vector |
| 07/12/2011 | US7977481 Pyrimidinyl-thiophene kinase modulators |
| 07/12/2011 | US7977477 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977468 Chromosome 3p21.3 genes are tumor suppressors |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/12/2011 | US7977369 Via 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-(1H-indole-4,7-dione )propenol |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |